An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Volume 192, Issue 2, Pages e3-e19
Publisher
American Thoracic Society
Online
2015-07-15
DOI
10.1164/rccm.201506-1063st
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bosentan in Pulmonary Hypertension Associated with Fibrotic Idiopathic Interstitial Pneumonia
- (2014) Tamera J. Corte et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
- (2014) Talmadge E. King et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
- (2014) Luca Richeldi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Trial of Acetylcysteine in Idiopathic Pulmonary Fibrosis
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Lung transplantation in idiopathic pulmonary fibrosis: a systematic review of the literature
- (2014) Kristin D Kistler et al. BMC Pulmonary Medicine
- Survival After Bilateral Versus Single-Lung Transplantation for Idiopathic Pulmonary Fibrosis
- (2013) Gabriel Thabut ANNALS OF INTERNAL MEDICINE
- Treatment of Idiopathic Pulmonary Fibrosis With Ambrisentan
- (2013) Ganesh Raghu ANNALS OF INTERNAL MEDICINE
- Sildenafil Preserves Exercise Capacity in Patients With Idiopathic Pulmonary Fibrosis and Right-sided Ventricular Dysfunction
- (2013) MeiLan K. Han et al. CHEST
- Endothelin Antagonism and Its Role in the Treatment of Hypertension
- (2013) Rebecca C. Moorhouse et al. CURRENT HYPERTENSION REPORTS
- Macitentan for the treatment of idiopathic pulmonary fibrosis: the randomised controlled MUSIC trial
- (2013) Ganesh Raghu et al. EUROPEAN RESPIRATORY JOURNAL
- Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis
- (2013) Kristian B Filion et al. GUT
- GRADE guidelines: 15. Going from evidence to recommendation—determinants of a recommendation's direction and strength
- (2013) Jeffrey C. Andrews et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Presence of a prothrombotic state in people with idiopathic pulmonary fibrosis: a population-based case–control study
- (2013) Vidya Navaratnam et al. THORAX
- Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials
- (2013) Joyce S Lee et al. Lancet Respiratory Medicine
- A Placebo-Controlled Randomized Trial of Warfarin in Idiopathic Pulmonary Fibrosis
- (2012) Imre Noth et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The big clinical trials in idiopathic pulmonary fibrosis
- (2012) Fabrizio Luppi et al. CURRENT OPINION IN PULMONARY MEDICINE
- Silent gastro-oesophageal reflux and microaspiration in IPF: mounting evidence for anti-reflux therapy?
- (2012) G. Raghu et al. EUROPEAN RESPIRATORY JOURNAL
- Riociguat for interstitial lung disease and pulmonary hypertension: a pilot trial
- (2012) Marius M. Hoeper et al. EUROPEAN RESPIRATORY JOURNAL
- The Dangers of Stopping a Trial Too Early
- (2012) Matthias Briel et al. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
- Prednisone, Azathioprine, andN-Acetylcysteine for Pulmonary Fibrosis
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of inhaled N-acetylcysteine monotherapy in patients with early stage idiopathic pulmonary fibrosis
- (2012) SAKAE HOMMA et al. RESPIROLOGY
- Idiopathic Pulmonary Fibrosis: Increased Survival with “Gastroesophageal Reflux Therapy”
- (2011) Ganesh Raghu AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- BUILD-3: A Randomized, Controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis
- (2011) Talmadge E. King et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Gastroesophageal Reflux Therapy Is Associated with Longer Survival in Patients with Idiopathic Pulmonary Fibrosis
- (2011) Joyce S. Lee et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
- (2011) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease
- (2011) D. B. Sprunger et al. EUROPEAN RESPIRATORY JOURNAL
- GRADE guidelines: 3. Rating the quality of evidence
- (2011) Howard Balshem et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
- (2011) Gordon Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
- (2011) Paul W Noble et al. LANCET
- Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
- (2011) Luca Richeldi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lung transplant for interstitial lung disease: outcomes for single versus bilateral lung transplantation
- (2011) N. C. De Oliveira et al. Interactive Cardiovascular and Thoracic Surgery
- Venous Thromboembolism and Risk of Idiopathic Interstitial Pneumonia
- (2010) Birgitte F. Sode et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Bilateral Lung Transplantation Offers Better Long-Term Survival, Compared With Single-Lung Transplantation, for Younger Patients With Idiopathic Pulmonary Fibrosis
- (2010) Seth D. Force et al. ANNALS OF THORACIC SURGERY
- GRADE guidelines: 2. Framing the question and deciding on important outcomes
- (2010) Gordon H. Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- A Controlled Trial of Sildenafil in Advanced Idiopathic Pulmonary Fibrosis
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Results of Lung Transplantation in Idiopathic Pulmonary Fibrosis Patients
- (2010) F.J. Algar et al. TRANSPLANTATION PROCEEDINGS
- An Official American Thoracic Society Policy Statement: Managing Conflict of Interest in Professional Societies
- (2009) Holger J. Schünemann et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Imatinib Treatment for Idiopathic Pulmonary Fibrosis
- (2009) Craig E. Daniels et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Idiopathic Pulmonary Fibrosis and Emphysema
- (2009) Mayra Mejía et al. CHEST
- Pirfenidone in idiopathic pulmonary fibrosis
- (2009) H. Taniguchi et al. EUROPEAN RESPIRATORY JOURNAL
- Sildenafil Therapy and Exercise Tolerance in Idiopathic Pulmonary Fibrosis
- (2009) Robert M. Jackson et al. LUNG
- Lung Transplantation in Pulmonary Fibrosis: Challenging Early Outcomes Counterbalanced by Surprisingly Good Outcomes Beyond 15 Years
- (2009) D. Keating et al. TRANSPLANTATION PROCEEDINGS
- Procoagulant signalling mechanisms in lung inflammation and fibrosis: novel opportunities for pharmacological intervention?
- (2008) R C Chambers BRITISH JOURNAL OF PHARMACOLOGY
- Antifibrotic action of pirfenidone and prednisolone: Different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis
- (2008) Hisashi Oku et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Vaso-active therapy can improve 6-min walk distance in patients with pulmonary hypertension and fibrotic interstitial lung disease
- (2008) Omar A. Minai et al. RESPIRATORY MEDICINE
- BUILD-1: A Randomized Placebo-controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis
- (2007) Talmadge E. King et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started